Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ross, L. F.
and
Woodle, E. S.
1998.
Organ Allocation.
p.
285.
Evans, Roger W.
and
Kitzmann, Daniel J.
1998.
AN ECONOMIC ANALYSIS OF KIDNEY TRANSPLANTATION.
Surgical Clinics of North America,
Vol. 78,
Issue. 1,
p.
149.
Dewar, Diane M.
1998.
Allocating Organ Transplant Services: What Can Be Learned from the United States Experience?.
Review of Social Economy,
Vol. 56,
Issue. 2,
p.
157.
MOATTI, JEAN‐PAUL
1998.
Researcher‐Driven Versus Policy‐Driven Economic Appraisal: The Case of Xenotransplantation.
Annals of the New York Academy of Sciences,
Vol. 862,
Issue. 1,
p.
188.
Rufat, Pierre
Fourquet, Florence
Conti, Filomena
Le Gales, Catherine
Houssin, Didier
and
Coste, Joël
1999.
COSTS AND OUTCOMES OF LIVER TRANSPLANTATION IN ADULTS.
Transplantation,
Vol. 68,
Issue. 1,
p.
76.
Hutton, J.
1999.
Immunosuppression under Trial.
p.
157.
Medin, Charlotte
Elinder, Carl‐Gustaf
Hylander, Britta
Blom, Birgit
and
Wilczek, Henryk
2000.
Survival of patients who have been on a waiting list for renal transplantation.
Nephrology Dialysis Transplantation,
Vol. 15,
Issue. 5,
p.
701.
Lorber, Marc I.
Fastenau, John
Wilson, David
DiCesare, Joseph
and
Hall, Michael L.
2000.
A prospective economic evaluation of basiliximab (Simulect®) therapy following renal transplantation.
Clinical Transplantation,
Vol. 14,
Issue. 5,
p.
479.
Pouteil-Noble, C.
Villar, E.
Babici, D.
and
Ecochard, R.
2000.
Transplantation and Changing Management of Organ Failure.
p.
115.
Kaló, Zoltán
Járay, Jeno
and
Nagy, Júlia
2001.
Economic Evaluation of Kidney Transplantation versus Hemodialysis in Patients with End-Stage Renal Disease in Hungary.
Progress in Transplantation,
Vol. 11,
Issue. 3,
p.
188.
Kaló, Zoltán
Járay, Jeno
and
Nagy, Júlia
2001.
Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary.
Progress in Transplantation,
Vol. 11,
Issue. 3,
p.
188.
Reimer, Jens
Franke, Gabriele H
Philipp, Thomas
and
Heemann, Uwe
2002.
Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine‐microemulsion.
Clinical Transplantation,
Vol. 16,
Issue. 1,
p.
48.
Marissal, J.P.
and
Sailly, J.C.
2002.
Éléments de problématique économique dans le domaine de l'épuration extra-rénale.
Santé Publique,
Vol. Vol. 14,
Issue. 2,
p.
107.
Craig, A.-M
McKechnie, T
McKenna, M
Klein, W
and
Schindler, T.M
2002.
A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation.
Transplantation Proceedings,
Vol. 34,
Issue. 5,
p.
1646.
Chilcott, James B.
Holmes, Michael W.
Walters, Stephen
Akehurst, Ronald L.
and
Nashan, Bjorn
2002.
The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.
Transplant International,
Vol. 15,
Issue. 9-10,
p.
486.
Sennfält, Karin
Magnusson, Martin
and
Carlsson, Per
2002.
Comparison of Hemodialysis and Peritoneal Dialysis — a Cost–Utility Analysis.
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis,
Vol. 22,
Issue. 1,
p.
39.
Walters, Stephen J.
Whitfield, Malcolm
Akehurst, Ronald L.
and
Chilcott, James B.
2003.
Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients.
PharmacoEconomics,
Vol. 21,
Issue. 2,
p.
129.
Salonen, Tapani
Reina, Tuomo
Oksa, Heikki
Sintonen, Harri
and
Pasternack, Amos
2003.
Cost analysis of renal replacement therapies in Finland.
American Journal of Kidney Diseases,
Vol. 42,
Issue. 6,
p.
1228.
Kaló, Z
2003.
Economic aspects of renal transplantation.
Transplantation Proceedings,
Vol. 35,
Issue. 3,
p.
1223.
Roels, Leo
Kalo, Zoltan
Boesebeck, Detlef
Whiting, James
and
Wight, Celia
2003.
Cost-benefit approach in evaluating investment into donor action: the German case.
Transplant International,
Vol. 16,
Issue. 5,
p.
321.